Hematopoietic growth factors

References

• Accuracy of the references is the responsibility of the authors.
   Google Scholar
• Dexter TM, Spooncer E. Growth and differentiation in the hemopoietic system. Annu Rev Cell Biol 1987: 3: 423–41
   PubMedGoogle Scholar
• Moore MA. In vivo and in vitro action of hematopoietic colony stimulating factors. Proc Am Assoc Cancer Res 1987: 28: 466–8
   Web of Science ®Google Scholar
• Caracciolo D, Wong GG, Rovera G. rhM-CSF requires subliminal concentrations of GM-SCF for optimal stimulation of human macrophage colony formation in vitro. J Exp Med 1987: 166: 1851–60
   PubMed Web of Science ®Google Scholar
• Williams DE, Straneva JE, Cooper S, et al. Interactions between purified murine colony-stimulating factors (natural CSF-1, recombinant GM-CSF, and recombinant IL-3) on the in vitro proliferation of purified murine granulocyte-macrophage progenitor cells. Exp Hematol 1987: 15: 1007–12
   PubMed Web of Science ®Google Scholar
• Moore MA, Warren DJ, Souza LM. Synergistic interaction between interleukin-1 and CSFs in hematopoiesis. In: Gale RP, Golde DW, eds. Recent advances in leukemia and lymphoma. Vol 61. Keystone, CO: Schering Corp-UCLA, 1987: 445–6
   Google Scholar
• Fibbe WE, van Damme J, Billiau A, et al. Interleukin-1 induces human marrow stromal cells in long-term culture to produce G-CSF and M-CSF. Blood 1988: 71: 430–5
   PubMed Web of Science ®Google Scholar
• Van Damme J, Schaafsma MR, Conings R, et al. Interleukin-1 induces different cytokines in human fibroblasts. Lymphokine Res 1989: 8(3): 289–92
   PubMedGoogle Scholar
• Sieff CA, Tsai S, Faller DV. Interleukin-1 induces cultured human endothelial cell production of granulocyte-macrophage colony- stimulating factor. J Clin Invest 1987: 79: 48–51
   PubMed Web of Science ®Google Scholar
• Fibbe WE, Daha M, Hiemstra PS, et al. Interleukin-1 and poly-rl poly(rC) induce production of granulocyte CSF, macrophage CSF, and granulocyte-macrophage CSF by human endothelial cells. Exp Hematol 1989: 17(3): 229–34
   PubMed Web of Science ®Google Scholar
• Rambaldi A, Young DC, Griffin JD. Expression of the M-CSF (CSF-1) gene by human monocytes. Blood 1987: 69: 1409–15
   PubMed Web of Science ®Google Scholar
• Vadhan-Raj S, Keating M, LeMaistre A, et al. Effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes. N Engl J Med 1987: 317: 1545–52
   PubMed Web of Science ®Google Scholar
• Groopman JE, Mitsuyasu RT, DeLeo MJ, et al. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on myelopoiesis in the acquired immunodeficiency syndrome. N Engl J Med 1987: 317: 593–8
   PubMed Web of Science ®Google Scholar
• Vadhan-Raj S, Suescher S, Broxmeyer HE, et al. Stimulation of myelopoiesis in patients with aplastic anemia by recombinant human granulocyte-macrophage colony-stimulating factor. N Engl J Med 1988: 319: 1628–34
   PubMed Web of Science ®Google Scholar
• Graber SE, Krantz SB. Erythropoietin and the control of red cell production. Ann Rev Med 1978: 29: 51–66
   PubMed Web of Science ®Google Scholar
• Koury ST, Bondurant MC, Koury MJ. Localization of erythropoietin synthesizing cells in murine kidneys by in situ hybridization. Blood 1988: 71: 524–7
   PubMed Web of Science ®Google Scholar
• Lacombe C, Da Silva JL, Bruneval P, et al. Peritubular cells are the site of erythropoietin synthesis in the murine, hypoxic kidney. J Clin Invest 1988: 81: 620–3
   PubMed Web of Science ®Google Scholar
• Miyake T, Kung CKH, Goldwasser E. Purification of human erythropoietin. J Biol Chem 1977: 252: 5558–64
   PubMed Web of Science ®Google Scholar
• Winearls EC, Oliver DO, Pippard MJ, et al. Effect of human erythropoietin derived from recombinant DNA on the anemia of patients maintained by chronic haemodialysis. Lancet 1986: 2: 1175–8
   PubMed Web of Science ®Google Scholar
• Eschbach JW, Egrie JC, Downing MR, et al. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. N Engl J Med 1987: 316: 73–8
   PubMed Web of Science ®Google Scholar
• Manes KRT, Olson NJ, Krantz SB, et al. Treatment of the anemia of rheumatoid arthritis with recombinant human erythropoietin: clinical and in vitro results. Blood 1987: 70(Suppl 1): 139A
   PubMedGoogle Scholar
• Lim VS, DeGowin RL, Zavala D, et al. Recombinant human erythropoietin treatment in pre-dialysis patients. Ann Intern Med 1989: 110(2): 108–14
   PubMed Web of Science ®Google Scholar
• Vellenga E, Delwel HR, Touw IP, et al. Patterns of acute myeloid leukemia colony growth in response to recombinant granulocyte- macrophage colony-stimulating factor (rGM-CSF). Exp Hematol 1987: 15: 652–6
   PubMed Web of Science ®Google Scholar
• Teshima H, Isikawa J, Kitayama H, et al. Clinical effects of recombinant human granulocyte colony-stimulating factor in leukemia patients: a phase II study. Exp Hematol 1989: 17: 853–8
   PubMed Web of Science ®Google Scholar
• Asano Y, Shibuya T, Okamura S, et al. Effect of human recombinant granulocyte- macrophage colony-stimulating factor and native granulocyte colony-stimulating factor on clonogenic leukemic blast cells. Cancer Res 1987: 47: 5647–8
   PubMed Web of Science ®Google Scholar
• Kelleher C, Miyauchi J, Wong G, et al. Synergism between recombinant growth factors, GM-CSF and G-CSF, acting on the blast cells of acute myeloblastic leukemia. Blood 1987: 69: 1498–1503
   PubMed Web of Science ®Google Scholar
• Miyauchi J, Kelleher CA, Yang YC, et al.: The effects of three recombinant growth factors, IL-3, GM-CSF and G-CSF, on the blast cells of acute myeloblastic leukemia maintained in short-term suspension culture. Blood 1987: 70(3): 657–63
   PubMed Web of Science ®Google Scholar
• Bruno E, Hoffman R Effect of interleukin-6 on in vitro human megakaryocytopoiesis: its interaction with other cytokines. Exp Hematol 1989: 17: 1038–43
   PubMed Web of Science ®Google Scholar
• Davis I, Maher D, Cebon J, et al. Pharmacokinetic and clinical studies of interleukin-4 (IL-4) in patients with malignancy. (Abstr) Proc Am Soc Clin Oncol 1991: 10: 287
   Google Scholar
• Akashi K, Shibuya T, Harada M, et al. Interleukin-4 suppresses the spontaneous growth of chronic myelomonocytic leukemia cells. J Clin Invest 1991: 88: 223–30
   PubMed Web of Science ®Google Scholar
• Defrance T, Fluckiger AC, Rossi JF, et al. Antiproliferative effects of interleukin-4 on freshly isolated non-Hodgkin malignant B-lymphoma cells. Blood 1992: 79: 990–6
   PubMed Web of Science ®Google Scholar